FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/107525 [Registered on: 02/04/2026] Trial Registered Prospectively
Last Modified On: 01/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Study comparing two Ayurvedic drugs (Nastapushpantak ras and Dashmula Trivrit siddha ghrita pana) in Udavatani Yonivyapad 
Scientific Title of Study   A Comparative Clinical Study to evaluate efficacy of Nastapushpantak rasa and Dashumla Trivrit Siddha Ghrita pana in Management of Udavatani Yonivyapad wsr to Primary Dysmenorrhea 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  KIRTI 
Designation  PG SCHOLAR  
Affiliation  SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA  
Address  OPD NO 2 OF PG DEPARTMENT OF PRASUTI TANTRA EVAUM STRI ROGA OF SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA

Mathura
UTTAR PRADESH
281401
India 
Phone  7988403076  
Fax    
Email  sainikirti3105@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Digamber P Shevale 
Designation  Professor 
Affiliation  SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA 
Address  OPD NO 2 OF PG DEPARTMENT OF PRASUTI TANTRA EVAUM STRI ROGA OF SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA

Mathura
UTTAR PRADESH
281401
India 
Phone  9271232369  
Fax    
Email  digs198180@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Digamber P Shevale 
Designation  Professor 
Affiliation  SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA 
Address  OPD NO 2 OF PG DEPARTMENT OF PRASUTI TANTRA EVAUM STRI ROGA OF SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA

Mathura
UTTAR PRADESH
281401
India 
Phone  9271232369  
Fax    
Email  digs198180@gmail.com  
 
Source of Monetary or Material Support  
SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER MATHURA UP 281401 
 
Primary Sponsor  
Name  SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER 
Address  DEPARTMENT OF PRASUTI TANTRA EVAM STRI ROGA SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER MATHURA 281401 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
KIRTI  SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER   DEPARTMENT OF PRASUTI TANTRA EVAM STRI ROGA SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER MATHURA 281401
Mathura
UTTAR PRADESH 
7988403076

sainikirti3105@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ICE Shri Dhanwantri Ayurvedic Medical College and Research Center Mathura ,Mahayogi Guru Gorakhnath AYUSH University, Gorakhpur, University,UP  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Nastapushpantak rasa, Reference: Bhaishaijya Ratnawali chapter 67 Shloka 51-57, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 10 Days, anupAna/sahapAna: Yes(details: Sukoshna jala), Additional Information: Drug duration should be starting 7 days before commencement of menstrual cycle till 3rd day of bleeding phase for 3 consecutive cycle
2Comparator ArmDrugClassical(1) Medicine Name: Dashmula Trivrit Siddha Ghrita pana, Reference: Asthanga Sangraha Uttara Tantra 39/42, Route: Oral, Dosage Form: Ghrita, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: Kwsona jala), Additional Information: Drug duration should after each menstrual cycle for 3 consecutive cycle
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  25.00 Year(s)
Gender  Female 
Details  1 Patients with signs and symptoms of udavartani yonivyapad as described in ayurvedic text
2 Females suffering with painful menstruation for 3 consecutive cycles
3 Female age group 13 to 25  
 
ExclusionCriteria 
Details  1 Cases of secondary dysmenorrhea with pelvic pathology
2 patient using IUCD
3 Patient having systemic disease likely to influence menstrual cycle
4 Patient having congenital anomalies leading to dysmenorrhea  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Changes in udavartani yonivyapad symptoms   Change in udavartani yonivaypad symptoms after 1 month
 
 
Secondary Outcome  
Outcome  TimePoints 
Significant changes in symptoms of Udavartani yonivyapad and also adverse events experienced by participants  3 consecutive cycles 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   From this study it is expected that the end of the study will be able to demonstrate the comparative effect of Nastapuspantak Rasa and Dashmula Trivrit Sidhha Ghrita Pana in Management of Udavartani Yonivyapad wsr to Primary Dysmenorrhea .It is further expected that this study will be able to provide the information related to the safety and efficacy of Nastapuspantak Rasa and Dashmula Trivrit Sidhha Ghrita Pana in Management of Udavartani Yonivyapad wsr to Primary Dysmenorrhea. 
Close